LineaRx Archives - LineaRx

Pile of newspapers on white background

LineaRx, Inc. Signs Licensing Agreement with LifeSensors

January 13, 2020

Read More email

APDN Reports 14 Development Customers for its Linear DNA Manufacturing Platform

November 25, 2019

Read More email

iCTC Platform Shows Superior Correlation over PSA as a Biomarker

October 1, 2019

Read More email

Medicare Coverage of CAR T-Cell Therapy Holds Positive Implications for LineaRx

August 12, 2019

Read More email

LineaRx Acquires Assets and Intellectual Property of Vitatex

August 8, 2019

Read More email

LineaRx Receives Multiple Orders for Linear DNA for Use in Therapeutic Development

July 1, 2019

Read More email

LineaRx Anticipates Expansion in Diagnostics Market

May 21, 2019

Read More email

LineaRx Achieves Higher Expression and Survival Rates in Human T Cells

April 29, 2019

Read More email

LineaRx Achieves Anti-CD19 Expression in Human CAR T Cells via Plasmid-Free Platform

April 8, 2019

Read More email

LineaRx to Announce DNA Vaccine Preclinical Data and Efficacy of In-Licensed CAR T Therapy

December 4, 2018

Read More email

LineaRx Provides Cost and Quality Advantages to Technogenetics

November 7, 2018

Read More email

At LineaRX, Putting The Horsepower Behind The CAR T

October 17, 2018

Read More email

LineaRx Licenses CAR T Drug Candidate, Initiates Pre-Clinical Development of Non-viral, Plasmid-free CAR T Manufacturing Platform

October 16, 2018

Read More email

LineaRx Secures New RNA Therapeutics Customers for Contract Research Services

October 1, 2018

Read More email

With New Spinoff, Biotech Goes All-In On DNA Sales

September 19, 2018

Read More email

APDN Forms Subsidiary, LineaRx, to Develop DNA for Biotherapeutics

September 18, 2018

Read More email